000 | 01880 a2200553 4500 | ||
---|---|---|---|
005 | 20250517085803.0 | ||
264 | 0 | _c20170303 | |
008 | 201703s 0 0 eng d | ||
022 | _a1348-4540 | ||
024 | 7 |
_a10.1507/endocrj.EJ15-0587 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aArimura, Hiroshi | |
245 | 0 | 0 |
_aInvestigation of the clinical significance of the growth hormone-releasing peptide-2 test for the diagnosis of secondary adrenal failure. _h[electronic resource] |
260 |
_bEndocrine journal _cJun 2016 |
||
300 |
_a533-44 p. _bdigital |
||
500 | _aPublication Type: Controlled Clinical Trial; Journal Article | ||
650 | 0 | 4 | _aAdministration, Intravenous |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 |
_aAdrenal Insufficiency _xblood |
650 | 0 | 4 |
_aAdrenocorticotropic Hormone _xblood |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aCorticotropin-Releasing Hormone _xadministration & dosage |
650 | 0 | 4 |
_aDwarfism, Pituitary _xblood |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHuman Growth Hormone _xblood |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHydrocortisone _xblood |
650 | 0 | 4 |
_aHypothalamic Diseases _xblood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOligopeptides _xadministration & dosage |
650 | 0 | 4 |
_aPituitary-Adrenal Function Tests _xmethods |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aHashiguchi, Hiroshi | |
700 | 1 | _aYamamoto, Kiyoaki | |
700 | 1 | _aShinnakasu, Atsushi | |
700 | 1 | _aArimura, Aiko | |
700 | 1 | _aKikuchi, Akira | |
700 | 1 | _aDeguchi, Takahisa | |
700 | 1 | _aHabu, Mika | |
700 | 1 | _aFujio, Singo | |
700 | 1 | _aArita, Kazunori | |
700 | 1 | _aNishio, Yoshihiko | |
773 | 0 |
_tEndocrine journal _gvol. 63 _gno. 6 _gp. 533-44 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1507/endocrj.EJ15-0587 _zAvailable from publisher's website |
999 |
_c25869032 _d25869032 |